Pathogenic Concepts in Pulmonary Arterial Hypertension Revisited: A Multigenerational Perspective

Area of Science:

• Biomedical research
• Vascular biology
• Pulmonary hypertension

Background:

• Next-generation omics, bioinformatics, and imaging are transforming biomedical research.
• Pulmonary hypertension research benefits from these advancements, enabling personalized medicine and risk stratification.
• Integrating new discovery platforms with decades of hypothesis-driven research is crucial for scientific progress.

Purpose of the Study:

• To debate and explore the integration of evolving disease frameworks within traditional research paradigms.
• To balance newer multi-omics approaches with classical hypothesis-driven science in pulmonary hypertension research.
• To address how to integrate unbiased analytic methods, interpret multi-omics findings, and review imaging for right ventricle disease understanding.

Main Methods:

• Discussions and pro/con debates among investigators at the 2024 American Thoracic Society (ATS) conference.
• Exploration of research paradigms in vascular biology, pulmonary hypertension, and right heart failure.
• Review of modern imaging methods for the right ventricle.

Main Results:

• Omics approaches offer broad insights and support personalized medicine but pose data management and translation challenges.
• Traditional reductionist approaches have yielded significant therapeutic breakthroughs.
• Combining omics and hypothesis-driven research holds potential for future discoveries in pulmonary hypertension.

Conclusions:

• A balanced integration of omics and traditional research is essential for advancing pulmonary hypertension understanding and treatment.
• Transdisciplinary collaboration is vital for overcoming challenges and achieving breakthroughs in pulmonary hypertension.
• Future progress in pulmonary hypertension requires coordinated efforts leveraging diverse scientific skillsets.